Jacqueline Harrington
Partner | New York
Jacqueline Harrington

Jacqueline Harrington practices in the area of complex litigation, with a focus on product liability and mass torts. Ms. Harrington has extensive experience handling litigation strategy, including all aspects of motion practice, discovery, expert work, trials and appeals.

Her clients have included Fortune 500 companies located nationwide involved in mass tort and other types of litigations in state and federal court. Prior to joining the firm, Ms. Harrington was an associate at another global law firm and represented clients in various complex litigation matters.

Ms. Harrington is a member of the Editorial Committee of the product liability and mass torts group’s newsletter, Dechert Re:Torts.

  • Fluoropolymer processor as national counsel in defense of personal injury actions alleging exposure to PFAS from personal protective equipment.
  • GSK in two class action lawsuits for alleged false advertising of its natural line of Chapstick products (NDCA, SDNY).
  • An American multinational manufacturer as national counsel in all lawsuits that have been filed across the country alleging that plaintiffs developed personal injuries such as mesothelioma from the use of certain consumer products that allegedly were contaminated with asbestos.
  • An investor-owned utility in hundreds of lawsuits arising out of the unprecedented 2017 and 2018 California wildfires, one of the largest and most complex sets of mass tort litigation in recent years.
  • An American software company in environmental litigation brought under the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), relating to the environmental remediation of Wisconsin’s Fox River and Michigan’s Kalamazoo river.
  • A technology company in actions filed in the Delaware Court of Chancery by a shareholder seeking inspection of books and records.  

*Includes matters handled at Dechert or prior to joining the firm.

  • Examining New Proposed MDL Rule Changes and What They Will Mean for Practitioners  – American Conference Institute: Drug & Medical Device Litigation (December 6, 2022)
  • Association of Corporate Counsel – Ethics and Compliance CLE Institute: The Attorney-Client Privilege and the Role of In-House Lawyers (Aug. 3, 2022)


    • Harvard University, A.B., 2005, cum laude
    • University of Michigan Law School, J.D., 2010, magna cum laude, Order of the Coif, Executive Editor of the Michigan Law Review
    • New York
    • United States District Court for the Eastern District of New York
    • United States District Court for the Southern District of New York
    • United States District Court for the Eastern District of Wisconsin
    • United States District Court for the Western District of Michigan